BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 23, 2014
View Archived Issues
Morphine tolerance reversed by blocking neuropeptide FF2 receptor
Read More
MYL3 gene mutation identified in hypertrophic cardiomyopathy pedigree
Read More
SomaGenics receives NIH funding to develop RNA technologies
Read More
Valneva begins phase II trial of VLA-84
Read More
Chimerix and ContraVir establish strategic collaboration for CMX-157
Read More
Merck & Co. expands oncology portfolio with acquisition of OncoEthix
Read More
Inovio Pharmaceuticals begins DNA immunotherapy trial for breast, lung and pancreatic cancer
Read More
Curis initiates phase I trial of CUDC-907 in patients with solid tumors
Read More
GlaxoSmithKline varicella zoster vaccine reduces incidence of shingles in phase III trial
Read More
Fate Therapeutics reports interim data from phase II trial of Prohema
Read More
Phase II trial of IPH-2201 begins in squamous cell carcinoma of the oral cavity
Read More
SciClone to commercialize clevidipine and bivalirudin in China
Read More
IND submitted for phase II study of NS2 for noninfectious anterior uveitis
Read More
Immunogenicity and safety of the Ebola virus vaccine cAd3-EBO in a phase I trial
Read More
University of Leicester patent describes compounds for bacterial infections
Read More
Xencor and Novo Nordisk form collaboration using Xencor's XmAb technologies
Read More
Marina Biotech and MiNA Therapeutics form agreement for saRNA-based therapeutics
Read More
Roche to acquire Dutalys
Read More
FDA approves AbbVie's Viekira Pak for chronic genotype 1 HCV infection
Read More
NETRIS Pharma creates first humanized monoclonal antibody against netrin-1
Read More
Bayer Schering Pharma describes novel thrombin inhibitors
Read More
Temple University prepares and tests novel glutamate uptake modulators
Read More
K(Ca)3.1 channel activators reported in Astellas Pharma patent
Read More
Xiapex receives positive opinion by CHMP for Peyronie's disease
Read More
Baxter applies for FDA approval of BAX-111 for Von Willebrand disease
Read More
First U.S. approval granted for nivolumab injection for metastatic melanoma
Read More
European marketing approval granted to Clinuvel's Scenesse
Read More